Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2021-04-29 Director's Dealing
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Director's Dealing 2021
Director's Dealing Classification · 99% confidence The document text is extremely short (489 characters) and its primary content is a title 'Trading by management and close relations of management' followed by a directive to 'Please read the full announcement in PDF' and a link to an attachment. This structure strongly indicates an announcement about a filing rather than the filing itself. The subject matter—trading by management and close relations—directly corresponds to insider transaction reporting, which is classified as Director's Dealing (DIRS). However, given the 'MENU VS MEAL' rule, since this is merely an announcement pointing to the full document, and it is a regulatory disclosure, it fits best as a Report Publication Announcement (RPA) or potentially a general Regulatory Filing (RNS). Since DIRS is a specific report type, and this is an announcement *of* that report, RPA is the most appropriate classification based on the provided rules for short announcement texts pointing to a full document. If the content were the actual transaction details, DIRS would be correct. Given the format, RPA is chosen.
2021-04-29 English
Annual Report (ESEF) 2020
Annual Report (ESEF) Classification · 100% confidence FY 2020
2021-04-29 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document explicitly states it contains 'Corrections made to the Annual Report 2020 published on February 2, 2021'. This indicates the document is an amendment or correction related to a previously issued Annual Report (10-K). Since it is not the full 10-K itself, but rather a specific update/correction document, it fits best under the general 'Regulatory Filings' (RNS) category as a specific regulatory update that doesn't match the primary definitions like ER, IR, or AR. Given the very short length (995 chars) and the nature of providing corrections to a prior filing, RNS is the most appropriate fallback.
2021-04-29 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 98% confidence The document is a short announcement (488 characters) regarding a stock buyback program. It explicitly directs the reader to an attached PDF for the full details of the transactions. According to the 'Menu vs Meal' rule, since this is a short announcement pointing to an attached report rather than the report itself, it is classified as a Report Publication Announcement.
2021-04-26 English
Transaction in Own Shares 2021
Transaction in Own Shares Classification · 98% confidence The document explicitly details transactions made under Novozymes' 'stock buyback program' and provides accumulated share purchase data, transaction values, and detailed daily trade logs for the period of April 19 to April 23, 2021. This content directly relates to the company repurchasing its own shares. According to the definitions, this corresponds to 'Transaction in Own Shares' (Code: POS). The document is a detailed report/update, not just an announcement of a report, and its length (34,516 chars) suggests it is more than a brief RPA.
2021-04-26 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a detailed report of share buyback transactions conducted by Novozymes under their stock buyback program. It provides a summary table of transactions for the week of April 12-16, 2021, and includes an extensive appendix of individual trade data (date, volume, price, venue). This document is a direct report of the company buying back its own shares, which falls under the 'Transaction in Own Shares' category.
2021-04-19 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.